Angle Closure Glaucoma Clinical Trial
Official title:
Evaluation of Clinical Decisions and Assessment of Those at Risk of Primary Angle Closure by Community Optometrists
Verified date | December 2023 |
Source | Moorfields Eye Hospital NHS Foundation Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Increases in the aging population has resulted in increased demand for glaucoma services. Glaucoma is a disease that if untreated, can lead to blindness. This increase and need for long term treatment with monitoring have resulted in a significant demand in the hospital eye service (HES). Many departments are now facing a considerable backlog of outpatient appointments and it's essential that these appointments are reserved for patients who are at risk of glaucoma blindness. Primary angle closure (PAC) glaucoma is a type of glaucoma, where the drainage route for the fluid inside the eye (known as the angle) is narrowed or blocked. It has been recently identified that approximately half of patients referred into the HES for a suspect narrow angle for further investigation are healthy and are immediately discharged. The exact reasons for these findings are unknown. This project will investigate clinical decisions by community optometrists who account for the majority of PAC referrals into the HES, as well as assessing their ability to evaluate those at risk of PAC. This project will also examine whether clinical agreement could be improved by providing an educational package. A clinical image database of angles will be acquired from glaucoma patients attending Moorfields Eye Hospital. A learning package discussing angle closure referral will also be developed. Community optometrists will be invited to complete a questionnaire on their clinical decision making. This will be followed by the vignette assessment, learning package and re-assessment. If this educational package and/or any other identifiers are found to improve agreement levels, this could reduce the number of referrals and enable community monitoring of those at low risk of developing PAC glaucoma in their lifetime.
Status | Active, not recruiting |
Enrollment | 163 |
Est. completion date | March 7, 2024 |
Est. primary completion date | March 7, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: New patients attending the glaucoma clinic at Moorfields Eye Hospital Exclusion Criteria: - They cannot be examined using a table mounted slit lamp due to physical limitations or have gross nystagmus. - Unable to consent - If they are unable to communicate in English and there is no available interpreter that meets requirements set out by Moorfields standard operating policies for patients - Under 18 years old |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Moorfields Eye Hospital NHS Foundation Trust, 162 City Road | London |
Lead Sponsor | Collaborator |
---|---|
Moorfields Eye Hospital NHS Foundation Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Agreement of community optometrists on measuring Limbal anterior chamber depth | Levels of agreement and precision of optometrist observers before and after intervention of online educational package in assessment of Limbal anterior chamber depth as a surrogate measure of angle width. Agreement will be measured via an online assessment vignette assessment package. Weighted Kappa statistic and levels agreement will be the outcome measures | 12 months | |
Secondary | Qualitative outcome measures from optometrists | Questionnaire based outcomes capturing data around current practice, qualifications and training, knowledge and resources available in practice with regards to angle closure diagnosis and referral | 12 months | |
Secondary | Qualitative outcome measures from patients | Difficulty in performing tests and satisfaction from the appointment (Likert scale 1-10), time taken (minutes) and costs of travel (£) to test site and waiting time to be examined from referral (months). | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00350428 -
Laser Iridotomy Versus Phacoemulsification in Acute Angle Closure
|
N/A | |
Recruiting |
NCT03626675 -
Anterior Segment Changes by Optical Coherence Tomography (OCT) in Phaco- Trabeculectomy
|
N/A | |
Completed |
NCT01895686 -
Comparison of Gonioscopy With Cirrus and Visante
|
||
Completed |
NCT02474238 -
Comparing Nd:YAG Laser and Sequential Double Frequency YAG-Nd:YAG Laser Iridotomy
|
N/A | |
Completed |
NCT02199158 -
Short-term Outcomes of Iridoplasty for Persistent Angle Closure Despite Patent Iridotomies
|
N/A | |
Completed |
NCT00524758 -
Oculusgen (Ologen) Glaucoma MMC Control in Estonia
|
Phase 3 | |
Active, not recruiting |
NCT04242108 -
Diagnostic Performance of Deep Learning for Angle Closure
|
||
Completed |
NCT04476810 -
Long Term Outcome of Combined Phacoemulsification and Excisional Goniotomy With the Kahook Dual Blade
|
N/A | |
Active, not recruiting |
NCT05576493 -
Combined Phacoemulsification and Diode Laser Therapy in Chronic Angle Closure Glaucoma
|
N/A |